Indivior Announces Q1 2025 Financial Results
Rhea-AI Summary
Indivior (Nasdaq/LSE: INDV) has announced the release of its Q1 2025 financial results for the period ending March 31, 2025. The company has made available its earnings release and investor presentation on their corporate website www.indivior.com.
A live webcast presentation is scheduled for 13:00 BST (8:00 am ET), to be hosted by CEO Mark Crossley. Participants can access the presentation through a webcast link or join telephonically by registering through the provided registration link.
Positive
- None.
Negative
- None.
- The earnings release can be found at www.indivior.com/investors
- The investor presentation can be found at www.indivior.com/investors (at 7:00 am ET)
There will be a live webcast presentation at 13:00 BST (8:00 am ET) hosted by Mark Crossley, CEO. The details are below.
Webcast link: https://edge.media-server.com/mmc/p/yn37cxqk
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BI4482694d7c294502b6a4dedd62e88c5b
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q1-2025-financial-results-302434707.html
SOURCE Indivior PLC